Tenaya Therapeutics, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Tenaya Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $43.00K, a 38.57% decline year-over-year.
- Tenaya Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $70.00K, a 87.36% decline year-over-year.
- Tenaya Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $554.00K, a 96.45% increase year-over-year.
- Tenaya Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $282.00K, a 22.61% increase year-over-year.
- Tenaya Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $112.00K, a 87.07% decline from fiscal 2024.
- Tenaya Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $866.00K, a 32.62% increase from fiscal 2023.
- Tenaya Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $653.00K, a 98.48% increase from fiscal 2022.
- Tenaya Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $329.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $43.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $112.00K 10-K · filed 2026-03-11 | |
| 2025-06-30 | $70.00K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $866.00K 10-K · filed 2026-03-11 | |
| 2024-06-30 | $554.00K 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $653.00K 10-K · filed 2025-03-10 | |
| 2023-06-30 | $282.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $329.00K 10-K · filed 2024-03-18 | |
| 2022-06-30 | $230.00K 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |